First, absence of metabolic and serum lipid profiles and assessments of steatosis and steatohepatitis data considering lipid metabolism related effects of PNPLA3 and especially TM6SF2 variants analyzed is a limitation, which would have otherwise provided useful insights to the study in this regard. This evidence concerns the gene PNPLA3 and steatosis.